Findx
EnglishEnglish
Dansk Dansk

Mycodern S.A. stock analysis MCD.PL

Mycodern Spółka Akcyjna is a Poland-based manufacturer of functional foods and dietary supplements. The company offers products including functional gummies, soft-gel capsules, hard capsules, oil- and liquid-based formulations, and functional drinks. It develops its own formulations through its in-house research and development unit and also performs contract manufacturing for third parties.

Its product lines feature branded and private-label offerings spanning multiple dosage forms. Among its supplement formats are gummies infused with vitamins and nutrients, softgels, and liquid or oil preparations aimed at delivering bioactive ingredients. The company also handles packaging and formulation adaptations to meet different market and client specifications.

Mycodern's operations are headquartered in Gdańsk, Poland, and its products are distributed in more than 25 countries, including markets in Europe. It operates modern production facilities equipped to manufacture a variety of supplement formats and supports both its own-branded sales and wholesale/contract manufacturing channels.

Consumer Defensive · Consumer Packaged Goods · Packaged Foods · Poland
Quality
Quality
Momentum
Momentum
Strength
Strength
Entry
Entry: N/A
Trend
Trend: N/A
‹
›

Click to see warnings

Neg. values

Log in
‹
›
Years
Lower P/E (Bear)
Sign in to view
Fair Value
Sign in to view
Upper P/E (Bull)
Sign in to view
Analysts
Sign in to view
Price: Financials: Q2 FY2026 / FY2025TTM presentEstimates: UnavailableScored as: Standard companyEvidence: IncompleteDetails

Freshness

  • Price through:
  • Latest annual period: FY2025 (); filed
  • Latest interim period: Q2 FY2026 (); filed
  • TTM period: ; used by: Quality, Strength
  • No future Diluted EPS estimate is available.
  • Target price: Date unknown, Analyst count unknown

Scoring profile

Effective scoring profile: Standard company

Report a suspected classification error

Score evidence

Quality: Unavailable; Not enough evidence; TTM used
Business Momentum: Unavailable; Not enough evidence; TTM not used
Strength: Unavailable; Not enough evidence; TTM used
  • Business Momentum score unavailable because too little of the model could be assessed. Missing: Cash generation, Earnings, Latest surprise, Estimate revisions, Profitability, Revenue, Share count.
  • Quality score unavailable because the required anchor metric is missing. Missing: Cash Conversion, Free Cash Flows, Gross Profitability, Margin Stability, Return on Capital.
  • Strength score unavailable because too little of the model could be assessed. Missing: Cyclicality, Debt & Payment Capacity, Profitability Durability, Earnings & Cash-Flow Resilience.

Sources and adjustments

Remaining score inputs are provider supplied.

  • Debt to operating cash flow: derived by Findx
  • FCF margin: approved fallback

Key stock metrics

Blended P/E  :
P/E (last full year) :
N/A
N/A
Blended EPS  :
PLN N/A
Blended EPS Yield  :
N/A
Dividend Yield :
(Trailing 12 months)
0.00%
Buyback Yield :
(Trailing 12 months)
N/A
Market Cap:PLN 51.31 M
EUR 11.66 M

Valuation basis

Analyst price target
How this valuation works
Yearly EPS growth  :
( years incl. estimates)
N/A

P/E Values

Upper P/E:
Fair Value P/E  :
Lower P/E:
Market P/E  :
Sign in to view

EPS Estimates

:
N/A
:
N/A
:
N/A

About Mycodern S.A.

Description, revenue sources, strengths and weaknesses

DESCRIPTION

Mycodern Spółka Akcyjna is a Poland-based manufacturer of functional foods and dietary supplements. The company offers products including functional gummies, soft-gel capsules, hard capsules, oil- and liquid-based formulations, and functional drinks. It develops its own formulations through its in-house research and development unit and also performs contract manufacturing for third parties.

Its product lines feature branded and private-label offerings spanning multiple dosage forms. Among its supplement formats are gummies infused with vitamins and nutrients, softgels, and liquid or oil preparations aimed at delivering bioactive ingredients. The company also handles packaging and formulation adaptations to meet different market and client specifications.

Mycodern's operations are headquartered in Gdańsk, Poland, and its products are distributed in more than 25 countries, including markets in Europe. It operates modern production facilities equipped to manufacture a variety of supplement formats and supports both its own-branded sales and wholesale/contract manufacturing channels.

ADDITIONAL INFO

It is very important that you understand this

Fair Value is an estimate, and you choose the basis it is built on. Do not invest based on our default without understanding how we calculate it.